Assessing the landscape of STXBP1 -related disorders in 534 individuals
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
Disease-causing variants in STXBP1 are among the most common genetic causes of neurodevelopmental disorders. However, the phenotypic spectrum in STXBP1-related disorders is wide and clear correlations between variant type and clinical features have not been observed so far. Here, we harmonized clinical data across 534 individuals with STXBP1-related disorders and analysed 19 973 derived phenotypic terms, including phenotypes of 253 individuals previously unreported in the scientific literature. The overall phenotypic landscape in STXBP1-related disorders is characterized by neurodevelopmental abnormalities in 95% and seizures in 89% of individuals, including focal-onset seizures as the most common seizure type (47%). More than 88% of individuals with STXBP1-related disorders have seizure onset in the first year of life, including neonatal seizure onset in 47%. Individuals with protein-truncating variants and deletions in STXBP1 (n = 261) were almost twice as likely to present with West syndrome and were more phenotypically similar than expected by chance. Five genetic hotspots with recurrent variants were identified in more than 10 individuals, including p.Arg406Cys/His (n = 40), p.Arg292Cys/His/Leu/Pro (n = 30), p.Arg551Cys/Gly/His/Leu (n = 24), p.Pro139Leu (n = 12), and p.Arg190Trp (n = 11). None of the recurrent variants were significantly associated with distinct electroclinical syndromes, single phenotypic features, or showed overall clinical similarity, indicating that the baseline variability in STXBP1-related disorders is too high for discrete phenotypic subgroups to emerge. We then reconstructed the seizure history in 62 individuals with STXBP1-related disorders in detail, retrospectively assigning seizure type and seizure frequency monthly across 4433 time intervals, and retrieved 251 anti-seizure medication prescriptions from the electronic medical records. We demonstrate a dynamic pattern of seizure control and complex interplay with response to specific medications particularly in the first year of life when seizures in STXBP1-related disorders are the most prominent. Adrenocorticotropic hormone and phenobarbital were more likely to initially reduce seizure frequency in infantile spasms and focal seizures compared to other treatment options, while the ketogenic diet was most effective in maintaining seizure freedom. In summary, we demonstrate how the multidimensional spectrum of phenotypic features in STXBP1-related disorders can be assessed using a computational phenotype framework to facilitate the development of future precision-medicine approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Membrane Fusion: Grappling with SNARE and SM Proteins
Südhof, T. C., & Rothman, J. E. (2009) · Science · doi:10.1126/science.1161748 · Cited by 2,027 · cited 1×
“Munc18-1 is a key organizer of the neuronal SNARE complex, the molecular machine driving synaptic vesicle fusion.(9,10) Homozygous Munc18 knockout mice have no synaptic transmission, emphasizing the crucial role of Sec1/Munc18 in the presynapse.”
Synaptic Assembly of the Brain in the Absence of Neurotransmitter Secretion
Verhage, M., Maia, A. S., Plomp, J. J., Brussaard, A. B., Heeroma, J. H., Vermeer, H., Toonen, R. F., Hammer, R. E., van den, T. K., Berg, et al. (2000) · Science · doi:10.1126/science.287.5454.864 · Cited by 1,428 · cited 1×
“Homozygous Munc18 knockout mice have no synaptic transmission, emphasizing the crucial role of Sec1/Munc18 in the presynapse.(11) In addition, the role of STXBP1 has been recognized in the Golgi complex and intracellular trafficking.”
Self-citationThe Human Phenotype Ontology in 2021
Köhler, S., Gargano, M., Matentzoglu, N., Carmody, L. C., Lewis-Smith, D., Vasilevsky, N. A., Danis, D., Balagura, G., Baynam, G., Brower, A. M., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1043 · Cited by 1,138 · cited 1×
“The Human Phenotype Ontology (HPO) is emerging as the lingua franca in the field and is widely used in clinical laboratory and research settings.(29,30) Large studies such as the Deciphering Developmental Disorders study, the UK Biobank, and prominent molecular diagnostic laboratories use HPO, and we have previously s…”
Self-citationThe human phenotype ontology: a tool for annotating and analyzing human hereditary disease
Robinson, P. N., Köhler, S., Bauer, S., Seelow, D., Horn, D., & Mundlos, S. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.09.017 · Cited by 1,034 · cited 1×
“The Human Phenotype Ontology (HPO) is emerging as the lingua franca in the field and is widely used in clinical laboratory and research settings.(29,30) Large studies such as the Deciphering Developmental Disorders study, the UK Biobank, and prominent molecular diagnostic laboratories use HPO, and we have previously s…”
Molecular machines governing exocytosis of synaptic vesicles
Jahn, R., & Fasshauer, D. (2012) · Nature · doi:10.1038/nature11320 · Cited by 970 · cited 1×
“Munc18-1 is a key organizer of the neuronal SNARE complex, the molecular machine driving synaptic vesicle fusion.(9,10) Homozygous Munc18 knockout mice have no synaptic transmission, emphasizing the crucial role of Sec1/Munc18 in the presynapse.”
Saitsu, H., Kato, M., Mizuguchi, T., Hamada, K., Osaka, H., Tohyama, J., Uruno, K., Kumada, S., Nishiyama, K., Nishimura, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.150 · Cited by 556
Lux, A. L., Edwards, S. W., Hancock, E., Johnson, A. L., Kennedy, C. R., Newton, R. W., O'Callaghan, F. J., Verity, C. M., & Osborne, J. P. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70199-x · Cited by 405
STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy
Stamberger, H., Nikanorova, M., Willemsen, M. H., Accorsi, P., Angriman, M., Baier, H., Benkel-Herrenbrueck, I., Benoit, V., Budetta, M., Caliebe, A., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002457 · Cited by 317
Self-citationClassification, Ontology, and Precision Medicine
Haendel, M. A., Chute, C. G., & Robinson, P. N. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1615014 · Cited by 317 · cited 1×
“Methods based on controlled vocabularies and bio-ontologies allow for heterogeneous clinical data to be harmonized across a wide range of sources.(28) The Human Phenotype Ontology (HPO) is emerging as the lingua franca in the field and is widely used in clinical laboratory and research settings.”
Efficacy of the Ketogenic Diet as a Treatment Option for Epilepsy: Meta-analysis
Henderson, C. B., Filloux, F. M., Alder, S. C., Lyon, J. L., & Caplin, D. A. (2006) · Journal of Child Neurology · doi:10.2310/7010.2006.00044 · Cited by 264 · cited 1×
“one use for seizure treatment, performed according to the United Kingdom Infantile Spasms Study (UKISS) at our institution,(37) and the ketogenic diet.(38) Excluding rescue medications, we compared”
Cited by
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
“‘SNAREopathies’ 99 cause DEEs, often accompanied by movement disorders 100–104 , due to pathogenic variants in genes including STXBP1 , SNAP2 , VAMP2 , DNM1 and CPLX1 , disrupting the presynaptic complex (Supplementary Table 1).”
The current landscape of epilepsy genetics: where are we, and where are we going?
Ruggiero, S. M., Xian, J., & Helbig, I. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001141 · Cited by 82
Self-citationAuvin, S., Arzimanoglou, A. A., Falip, M., Striano, P., & Cross, J. H. (2024) · Epilepsia Open · doi:10.1002/epi4.13075 · Cited by 55
Self-citationEpilepsy Course and Developmental Trajectories in STXBP1 -DEE
Balagura, G., Xian, J., Riva, A., Marchese, F., Zeev, B. B., Ríos, L., Sirsi, D., Accorsi, P., Amadori, E., Astrea, G., et al. (2022) · Neurology Genetics · doi:10.1212/nxg.0000000000000676 · Cited by 52
“A recent study used a computational framework to analyze the phenotypic landscape of >500 individuals with STXBP1related disorders, being the most extensive analysis to date.(31) The study shows that protein-truncating variants and deletions in STXBP1 were more phenotypically similar compared with missense variants; f…”
Self-citationDelineating clinical and developmental outcomes in STXBP1-related disorders
Xian, J., Thalwitzer, K. M., McKee, J. L., Sullivan, K. R., Brimble, E., Fitch, E., Toib, J., Kaufman, M. C., deCampo, D., Cunningham, K. G., et al. (2023) · Brain · doi:10.1093/brain/awad287 · Cited by 49
“As previously recognized, 3 we found that epilepsy histories di-verge between individuals with missense variants compared to PTV and deletions.”
InfluentialSelf-citationSCN1A gain‐of‐function mutation causing an early onset epileptic encephalopathy
Clatot, J., Parthasarathy, S., Cohen, S. R., McKee, J. L., Massey, S. L., Somarowthu, A., Goldberg, E. M., & Helbig, I. (2022) · Epilepsia · doi:10.1111/epi.17444 · Cited by 48
Self-citationParthasarathy, S., Ruggiero, S. M., Gélot, A., Soardi, F. C., Ribeiro, B. F., Pires, D. E. V., Ascher, D. B., Schmitt, A., Rambaud, C., Represa, A., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.11.002 · Cited by 38
Self-citationAltered synaptic connectivity in an in vitro human model of STXBP1 encephalopathy
McLeod, F., Dimtsi, A., Marshall, A. C., Lewis‐Smith, D., Thomas, R. H., Clowry, G. J., & Trevelyan, A. J. (2022) · Brain · doi:10.1093/brain/awac396 · Cited by 36
“Treatment of STXBP1-related disorders is challenging, requiring a personalized treatment plan.(10) This model system could serve as a crucial bridge to facilitate the devel-”
Self-citationA disease concept model for STXBP1 ‐related disorders
Sullivan, K. R., Ruggiero, S. M., Xian, J., Thalwitzer, K. M., Ali, R., Stewart, S., Cosico, M., Steinberg, J., Goss, J. R., Pfalzer, A. C., et al. (2023) · Epilepsia Open · doi:10.1002/epi4.12688 · Cited by 32
Self-citationSpecchio, N., Micco, V. D., Aronica, E., Auvin, S., Balestrini, S., Brunklaus, A., Gardella, E., Scheper, M., Taglialatela, M., Trivisano, M., et al. (2025) · Epilepsia · doi:10.1111/epi.18209 · Cited by 34
Self-citationFreibauer, A., Wohlleben, M., & Boelman, C. G. (2023) · Genes · doi:10.3390/genes14122179 · Cited by 32
“In patients identified with STXBP1 variants, 38% of patients were identified as being non-verbal above the age of 11 [2], although in small cohorts, as many as 71% of adults with STXBP1 were non-verbal [22].”
BackgroundInfluentialClinical trials for Lennox–Gastaut syndrome: Challenges and priorities
Knowles, J. K., Warren, A. E. L., Mohamed, I., Stafstrom, C. E., Koh, H. Y., Samanta, D., Shellhaas, R. A., Gupta, G., Dixon‐Salazar, T., Tran, L., et al. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52211 · Cited by 31
Na, J., Lee, H. J., & Lee, Y. (2025) · Nutrients · doi:10.3390/nu17060979 · Cited by 31
“Furthermore, emerging evidence suggests that ketones may directly modulate synaptic activity and enhance mitochondrial function, to thereby improve cellular resilience against hyperexcitability [55,56].”
Daniali, M., Galer, P. D., Lewis‐Smith, D., Parthasarathy, S., Kim, E., Salvucci, D. D., Miller, J. M., Haag, S., & Helbig, I. (2022) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2023.102523 · Cited by 27
Self-citationSamanta, D. (2025) · Children · doi:10.3390/children12040481 · Cited by 29
“Additionally, the ketogenic diet has shown efficacy in STXBP1-related seizures [75,76].”
InfluentialComputational analysis of neurodevelopmental phenotypes: Harmonization empowers clinical discovery
Lewis‐Smith, D., Parthasarathy, S., Xian, J., Kaufman, M. C., Ganesan, S., Galer, P. D., Thomas, R. H., & Helbig, I. (2022) · Human Mutation · doi:10.1002/humu.24389 · Cited by 21
“We have previous examined longitudinal phenotypic data by extracting features from EMR (Ganesan et al., 2020; D. Lewis ‐ Smith, Ganesan, et al., 2021; Xian et al., 2021).”
InfluentialSelf-citationCirculating Blood-Based Proteins in Psychopathology and Cognition: A Mendelian Randomization Study
Bhattacharyya, U., John, J., Lam, M., Fisher, J., Sun, B. B., Baird, D. A., Burgess, S., Chen, C., & Lencz, T. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.0033 · Cited by 22
“Additionally, reduced levels of syntaxin binding protein 1 (STXBP1, critical to release of neurotransmitters from synaptic vesicles) were associated with schizophrenia; loss of function mutations in this gene cause a range of neurodevelopmental disorders 51 .”
Microcircuit failure in STXBP1 encephalopathy leads to hyperexcitability
dos Santos, A. B., Larsen, S. D., Guo, L., Barbagallo, P., Montalant, A., Verhage, M., Sørensen, J. B., & Perrier, J.-F. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101308 · Cited by 17
“6 9 Among the mutations leading to STXBP1 encephalopathy are truncations, microdeletions, and missense mutations.”
BackgroundSelf-citationEarly life seizures and epileptic spasms in STXBP1 ‐related disorders
Thalwitzer, K. M., Xian, J., de Campo, D., Parthasarathy, S., Magielski, J. H., Sullivan, K. R., Goss, J. R., Rigby, C. S., Boland, M. J., Prosser, B. L., et al. (2024) · Epilepsia · doi:10.1111/epi.17886 · Cited by 20
“5 For example, we assessed the number of time intervals in which phenobarbital was prescribed and the change in SF during these intervals compared to the change in SF across intervals in which individuals received a medication other than phenobarbital.”
MethodSelf-citationKim, J. H., Chen, W., Chao, E. S., Rivera, A. M., Kaku, H. N., Jiang, K., Lee, D., Chen, H., Vega, J. M., Chin, T. V., et al. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1806-23.2024 · Cited by 19
“Other clinical features include developmental delay, autistic traits, hyperactivity, anxiety, and aggressive behaviors (Stamberger et al., 2016; Suri et al., 2017; Xian et al., 2022).”
InfluentialBase-edited cynomolgus monkeys mimic core symptoms of STXBP1 encephalopathy
Lu, Z., He, S., Jiang, J., Zhuang, L., Wang, Y., Yang, G., Jiang, X., Nie, Y., Fu, J., Zhang, X., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.03.001 · Cited by 19
Quantitative EEG Biomarkers in the Genetic Epilepsies and Associations With Neurologic Outcomes
Galer, P. D., McKee, J. L., Ruggiero, S. M., Kaufman, M. C., Ojemann, W. K. S., Ganesan, S., Ganesan, S., Gonzalez, A. K., Cao, Q., Litt, B., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000214148 · Cited by 18
Self-citationdeCampo, D., Xian, J., Karlin, A. R., Sullivan, K. R., Ruggiero, S. M., Galer, P. D., Ramos, M., Abend, N. S., Gonzalez, A., & Helbig, I. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1161161 · Cited by 18
Self-citation(2024) · doi:10.7554/elife.88619.3 · Cited by 17
Accelerating therapeutic development and clinical trial readiness for STXBP1 and SYNGAP1 disorders
Marotta, N., Boland, M. J., & Prosser, B. L. (2024) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2024.101576 · Cited by 18
Self-citationClinical signatures of SYNGAP1-related disorders through data integration
McKee, J. L., Magielski, J. H., Xian, J., Cohen, S. R., Toib, J., Harrison, A., Chen, C., Kim, D., Rathod, A., Brimble, E., et al. (2025) · Genetics in Medicine · doi:10.1016/j.gim.2025.101419 · Cited by 17
Self-citationDeciphering the Natural History of SCN8A -Related Disorders
Magielski, J. H., Cohen, S. R., Kaufman, M. C., Parthasarathy, S., Xian, J., Brimble, E., Fitter, N., Furia, F., Gardella, E., Møller, R. S., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000213533 · Cited by 17
“The study was approved by the Institutional Review Board”
Self-citationQuiroz, V., Alecu, J. E., Zubair, U., Bernardi, K., Zaman, Z., Rong, J., Tam, A., Kunta, A., Agianda, H. A. P., Battaglia, N., et al. (2025) · Brain · doi:10.1093/brain/awaf297 · Cited by 16
The clinical and genetic spectrum of paediatric speech and language disorders
Magielski, J. H., Ruggiero, S. M., Xian, J., Parthasarathy, S., Galer, P. D., Ganesan, S., Back, A., McKee, J. L., McSalley, I., Gonzalez, A. K., et al. (2024) · Brain · doi:10.1093/brain/awae264 · Cited by 16
Self-citationKessi, M., Chen, B., Shan, L.-D., Wang, Y. X., Yang, L., Yin, F., He, F. P., Peng, J., & Wang, G. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01474-2 · Cited by 15
Breaking the Synaptic Vesicle Cycle: Mechanistic Insights into Presynaptic Dysfunctions in Epilepsy
Jiang, K., Yang, L.-T., & Xue, M. (2025) · Epiliepsy currents/Epilepsy currents · doi:10.1177/15357597251317898 · Cited by 15
“31 STXBP1 haploinsuf fi ciency is considered as the main disease mechanism because about 50% of affected individuals carry a truncating variant.”
André, T., van Berkel, A. A., Singh, G., Abualrous, E. T., Diwan, G. D., Schmenger, T., Braun, L., Malsam, J., Toonen, R. F. G., Freund, C., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.03.007 · Cited by 13
“Almost 50% of the cases are caused by missense variants with no major phenotypic segregation, while the other 50% consist of classical loss of function variants: whole-gene deletions, nucleotide insertions or deletions, frame shifts, nonsense mutations, and splice-altering mutations (3,4,6 – 13).”
InfluentialSelf-citationAeran, R., Tanenhaus, A., Sears, S. M. S., Moerke, N. J., Miller, A., Artur, C., Bouhlal, Y., Bove, P. F., de Arce, A. J. D., Shimizu, S., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.05.011 · Cited by 13
Thalwitzer, K. M., Driedger, J. H., Xian, J., Saffari, A., Zacher, P., Bölsterli, B. K., Ruggiero, S. M., Sullivan, K. R., Datta, A., Kellinghaus, C., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207550 · Cited by 13
Self-citationSTXBP1: fast-forward to a brighter future – a patient organization perspective
Goss, J. R., Prosser, B. L., Helbig, I., & Rigby, C. S. (2024) · Therapeutic Advances in Rare Disease · doi:10.1177/26330040241257221 · Cited by 13
“1 8 A recent estimate of the incidence of syntaxin-binding protein 1 related disorder STXBP1-RD is approximately 1:30,000 births 9 and STXBP1 is the fifth most implicated gene associated with epileptic developmental disorders, 10 suggesting that the disease is not as rare as once believed.”
BackgroundSelf-citationSong, T., Deng, J., Chen, C., Wang, X., Han, T., Wang, X., Fang, T., Tian, X., & Fang, F. (2024) · Epilepsia Open · doi:10.1002/epi4.12899 · Cited by 11
“23 The STXBP1 gene encodes a syntaxin-binding protein that facilitates neurotransmitter release between neurons by vesicle fusion.”
BackgroundResultPathogenic UNC13A variants cause a neurodevelopmental syndrome by impairing synaptic function
Asadollahi, R., Ahmad, A., Boonsawat, P., Hinzen, J. S., Lohse, M., Bouazza-Arostegui, B., Sun, S., Utesch, T., Sommer, J. D., Ilić, D., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02361-5 · Cited by 9
“The most common SNAREopathy is the STXBP1 encephalopathy, which is diagnosed in 3.3–3.8 out of every 10,000 births 59,60 .”
InfluentialSelf-citationSTXBP1 Stop‐Loss Mutation Associated with Complex Early Onset Movement Disorder without Epilepsy
Spaull, R., Steel, D., Barwick, K. E., Prabhakar, P., Wakeling, E. L., & Kurian, M. A. (2022) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13509 · Cited by 11
van Berkel, A. A., Koopmans, F., Gonzalez‐Lozano, M. A., Lammertse, H. C. A., Feringa, F. M., Bryois, J., Sullivan, P. F., Smit, A. B., Toonen, R. F. G., & Verhage, M. (2022) · eNeuro · doi:10.1523/eneuro.0186-22.2022 · Cited by 12
“Interestingly, the effects of single CAM KOs on synapse formation are relatively mild, potentially because of redundancy (Robbins et al., 2010; Yim et al., 2013; Südhof, 2018).”
Self-citationDisease-linked mutations in Munc18-1 deplete synaptic Doc2
Guiberson, N. G. L., Black, L. S., Haller, J. E., Brukner, A., Abramov, D., Ahmad, S., Xie, Y. X., Sharma, M., & Burré, J. (2024) · Brain · doi:10.1093/brain/awae019 · Cited by 11
“19 However, we do not expect that dysfunction of Doc2A and Doc2B is the only source of pathology in STXBP1 encephalopathies.”
Guzman, S., Ruggiero, S. M., Ganesan, S., Ellis, C. A., Harrison, A., Sullivan, K. R., Stark, Z., Brown, N. J., Kana, S. L., Tuttle, A., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.04.011 · Cited by 12
Self-citationAkkoyunlu, D. S., Kara, B., Özer, T., Deniz, A., GÜNEŞ, A. S., Işik, E. B., Doğruoğlu, B., İlkay, Z., Yilmaz, M., Sahin, S., et al. (2025) · Genes · doi:10.3390/genes16101152 · Cited by 10
“Our findings support prior reports that EEG patterns may partly reflect the functional consequences of different variant types [33].”
Quantitative EEG biomarkers for STXBP1 ‐related disorders
Cossu, A., Furia, F., Proietti, J., Ancora, C., Reale, C., Darra, F., Previtali, R., Bernardina, B. D., Rubboli, G., Beniczky, S., et al. (2024) · Epilepsia · doi:10.1111/epi.18154 · Cited by 9
Self-citationvan Till, S. A. L., Sybesma, S., Bruining, H., Verhage, M., & Bunnik, E. M. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03314-7 · Cited by 9
“RD have an intellectual disability and developmental delay, and 89% are affected by epilepsy/ seizures [6, 7].”
Self-citationEffects of the ketogenic diet therapy in patients with STXBP1-related encephalopathy
Nam, J. Y., Teng, L., Cho, K. U., Kang, H., Lee, J. S., Kim, H. D., & Kim, S. H. (2022) · Epilepsy Research · doi:10.1016/j.eplepsyres.2022.106993 · Cited by 9
Self-citationEarly mortality in STXBP1-related disorders
Furia, F., Rigby, C. S., Scheffer, I. E., Allen, N. M., Baker, K., Hengsbach, C., Kegele, J., Goss, J. R., Gorman, K. M., Misra‐Isrie, M., et al. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07783-3 · Cited by 8
Self-citationMonogenic Epilepsies in Adult Epilepsy Clinics and Gene-Driven Approaches to Treatment
Clayton, L. M. S., Vakrinou, A., Balestrini, S., & Sisodiya, S. M. (2025) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-025-01413-x · Cited by 8
Healthcare utilization and clinical characteristics of genetic epilepsy in electronic health records
Boßelmann, C. M., Ivaniuk, A., John, M. S., Taylor, S. C., Krishnaswamy, G., Milinovich, A., Leu, C., Gupta, A., Pestana‐Knight, E., Najm, I., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae090 · Cited by 7
“11,12 Deep quantitative phenotypic analysis has greatly enhanced our understanding of the clinical spectrum of disorders related to variants in SCN2A , 13 STXBP1 14 and others.”
Ruano-Rodríguez, S., Navarro-Alonso, M., Domínguez-Velasco, B., Álvarez‐Dolado, M., & Esteban, F. J. (2025) · BioTech · doi:10.3390/biotech14010011 · Cited by 9
“Some recurrent variants, such as p.Arg406His, p.Arg406Cys, and p.Arg292His, are considered mutational hotspots [2,24,25] (Figure 1). p.Arg292His, are considered mutational hotspots [2,24,25] (Figure 1). hope to contribute to the ongoing e ff orts to improve diagnosis, treatment, and quality of life…”
InfluentialGenome Sequencing of Idiopathic Speech Delay
Eising, E., Vino, A., Mabie, H. L., Campbell, T. F., Shriberg, L. D., & Fisher, S. E. (2024) · Human Mutation · doi:10.1155/2024/9692863 · Cited by 8
Félix, A. J., Brown, B. L., Marotta, N., Gessner, M. J., Houserova, M., Huerta-Ocampo, I., Wilson, T., Randell, R., Dawicki-McKenna, J. M., Reinhardt, D., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03698-x · Cited by 7
Self-citationInvestigation of epilepsy-related genes in a Drosophila model
Qu, X.-C., Lai, X., He, M., Zhang, J., Xiang, B., Liu, C., Huang, R., Shi, Y., & Qiao, J. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00877 · Cited by 5
“Precision medicine is a transformative approach www.nrronline.org Established (Oyrer et al., 2018) Established (Oyrer et al., 2018; Strzelczyk and Schubert-Bast, 2022; Wirrell et al., 2022) Potential (Strzelczyk and Schubert-Bast, 2022) Potential (Lagae, 2021; Strzelczyk and Schubert-Bast, 2022) Potential (Nissenkorn…”
Harrison, A., Magielski, J. H., McSalley, I., Ganesan, S., Prentice, A. J., Cunningham, K. G., Pierce, S. R., Boland, M. J., Prosser, B. L., Helbig, I., et al. (2025) · Epilepsia · doi:10.1111/epi.18469 · Cited by 5
“This relatively high frequency aligns more with SCN1A - related disorders 20–22 or SCN2A - related disorders 23–25 than with other synapse disorders such as STXBP1 - related disorders 26,27 or DNM1 - related disorders, 28,29 where familial inheritance is virtually non-existent.”
Self-citationGallo, N. B., Annand, J. W., Clarner, P., Harvey, B., Morozova, E., Ehrenfels, C., Jiang, T., Yuan, L., Kashyap, S., Lü, X., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.03.027 · Cited by 5
Truncated DNM1 variant underlines developmental delay and epileptic encephalopathy
Afsar, T., Huang, X., Shah, A. A., Abbas, S., Bano, S., Mahmood, A., Hu, J., Razak, S., & Umair, M. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1266376 · Cited by 5
Advances in big data and omics: Paving the way for discovery in childhood epilepsies
Magielski, J. H., McSalley, I., Parthasarathy, S., McKee, J. L., Ganesan, S., & Helbig, I. (2024) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2024.101634 · Cited by 5
Self-citationWONOEP appraisal: Genetic insights into early onset epilepsies
Quatraccioni, A., Cases‐Cunillera, S., Balagura, G., Coleman, M., Rossini, L., Mills, J. D., Casillas-Espinosa, P. M., Moshé, S. L., Sankar, R., Baulac, S., et al. (2024) · Epilepsia · doi:10.1111/epi.18124 · Cited by 6
“37,98,99 In the context of DEEs, the relationship between epileptic activity and developmental impairment is often unclear, and the lack of genotype–phenotype correlations makes prognosis challenging for these patients.”
Self-citationGenetic epilepsies as a cause of seizures in Neonates
Numis, A. L., Cornet, M., & Glass, H. C. (2025) · Seminars in Perinatology · doi:10.1016/j.semperi.2025.152146 · Cited by 4
Pierce, S. R., Orlando, J. M., Cunningham, K. G., Ruggiero, S. M., Kaufman, M. C., McKee, J. L., & Helbig, I. (2026) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.70265 · Cited by 4
Self-citationÖttl, M., Toonen, R. F. G., & Verhage, M. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae035 · Cited by 4
“Indeed, mutations in STXBP1 are associated with various cases of neurodevelopmental delay and encephalopathies, with most common symptoms being epilepsy, motor problems and intellectual disability [9–11].”
BackgroundSelf-citationAdvances in STXBP1 encephalopathy research and translational opportunities
Zheng, Y., Li, F., & Shi, J. (2024) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2024.100134 · Cited by 4
Amllal, N., Lyahyai, J., Elalaoui, S. C., Kadiri, Y. E., & Sefiani, A. (2024) · Molecular Syndromology · doi:10.1159/000538115 · Cited by 4
“More than 88% of individuals experienced their fi rst seizure within the fi rst year of life, including neonatal seizures in 47% of cases [10].”
InfluentialTakeda, K., Miyamoto, Y., Yamamoto, H., Iwasaki, T., Sumitomo, N., Takeshita, E., Ishii, A., Hirose, S., & Shimizu, N. (2022) · Pediatric Reports · doi:10.3390/pediatric14040046 · Cited by 4
“conducted a comparative effectiveness assessment of ASM and treatment responses in STXBP1-related disorders in 534 individuals and ACTH therapy was more likely to reduce seizure frequency than to exacerbate symptoms or have no effect [18].”
MethodBhattacharyya, U., John, J., Lam, M., Fisher, J., Sun, B. B., Baird, D. A., Chen, C.-Y., & Lencz, T. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.02.946 · Cited by 5
Evaluation, Diagnosis, and Treatment of Concomitant Movement Disorders in Genetic Epilepsies
Garris, J. F., Abbott, M., Axeen, E. T., Tochen, L. S., & Schreiber, J. M. (2025) · Epiliepsy currents/Epilepsy currents · doi:10.1177/15357597251323917 · Cited by 3
Visual Function Characteristics in STXBP1 Epileptic Encephalopathy Patients
Rosa, A., Nowakowska, D., Rosa, P., Simiera, J., Gliniany, A., Zawadka, M., Szczałuba, K., Przysło, Ł., Szymańska, K., Loba, P., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14196840 · Cited by 3
“Seizures occurred in 92.4% of patients during the first year of life, supporting prior epidemiological data reporting a prevalence of up to 95% [4,5,7,8].”
InfluentialClinical trajectories and medication response in TBC1D24 ‐related epilepsies
Mondragon, E., Magielski, J. H., Bane, B., Nolan, J., Ruggiero, S. M., Armstrong, D. M., Arnold, S., Sirsi, D., Helbig, I., & McKee, J. L. (2025) · Epilepsia · doi:10.1111/epi.70013 · Cited by 3
“We performed a systematic analysis based on reconstructed seizure and medication histories as conducted previously for STXBP1 - related disorders, 10,12,16 SYNGAP1 - related disorders, 17 and SCN8A - related disorders.”
Self-citationA prospective natural history study protocol for clinical trial readiness in synaptic disorders
McKee, J. L., Ruggiero, S. M., Cunningham, K. G., Coyne, J., McSalley, I., Kaufman, M. C., Bane, B., Chisari, T., Toib, J., Glatts, C., et al. (2026) · Epilepsia · doi:10.1002/epi.70374 · Cited by 4
“RD and SYNGAP1 - RD.”
InfluentialSelf-citationSamanta, D. (2026) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2026.111194 · Cited by 3
Wang, H., Chen, X., Liu, Z., Chen, C., Liu, X., Huang, M., & Zhou, Z. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1146875 · Cited by 3
Precision Medicine in Epilepsy Management; GET Application (Gene, Epilepsy, Treatment)
Asadi‐Pooya, A. A. (2023) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000549 · Cited by 3
Expression of the schizophrenia associated gene FEZ1 in the early developing fetal human forebrain
Alhesain, M., Ronan, H., LeBeau, F. E. N., & Clowry, G. J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1249973 · Cited by 3
“STXBP1 has been associated with schizophrenia (Behan et al., 2009) although with less evidence than NRXN1 but is more commonly associated with infantile epilepsy (Xian et al., 2022).”
Phenotypic analysis of 11,125 trio exomes in neurodevelopmental disordersPreprint
Ganesan, S., Ruggiero, S. M., Parthasarathy, S., Galer, P. D., Lewis‐Smith, D., McSalley, I., Cohen, S. R., Lusk, L. G., Prentice, A. J., McKee, J. L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.11.642649 · Cited by 3
“…combined with statistical methods have previously been used to discover novel genetic etiologies in neurodevelopmental disorders 6 , map the phenotypic landscape of known genetic etiologies 11 , and address the longitudinal trajectories within a subset of genetic neurodevelopmental disorders 9,13 .”
Self-citationUncovering common genetic risk factors in migraine and epilepsy through whole exome sequencing
Sahu, P., Kashyap, S., Kumar, A., & Munshi, A. (2025) · Epileptic Disorders · doi:10.1002/epd2.70147 · Cited by 2
Epilepsy‐Dyskinesia Syndromes: The Venn Diagram of Genetic Epilepsy and Movement Disorders
Bernardi, K., Alecu, J. E., Achkar, C. M. E., Tochen, L. S., Pearl, P. L., & Ebrahimi‐Fakhari, D. (2026) · Movement Disorders · doi:10.1002/mds.70403 · Cited by 2
Lin, W. (2022) · Advanced Genetics · doi:10.1002/ggn2.202200018 · Cited by 2
Infantile epileptic spasm syndrome as a new NR2F1 gene phenotype
Liang, Y., Wan, L., Liu, X., Zhang, J., Zhu, G., & Yang, G. (2023) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10309 · Cited by 2
“…structural brain abnormalities, and up to 41% of the cases are attributable to genetic factors, including trisomy 21 and pathogenetic variants in ARX , CDKL5 , STXBP1 , IQSEC2 , TSC1 and TSC2 (Olson et al., 2019; Liu et al., 2018; Xian et al., 2022;Bernardo et al., 2019; Takeshita et al., 2020).”
BackgroundNa, J., & Lee, Y. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1305404 · Cited by 2
Schaare, D., Lusk, L. G., Karlin, A. R., Kaufman, M. C., Magielski, J. H., Sarasua, S. M., Allison, K., Boccuto, L., & Helbig, I. (2025) · Neurology Genetics · doi:10.1212/nxg.0000000000200228 · Cited by 2
Self-citationCharacterizing Key Correlates of Sleep Problems Across Rare Neurodevelopmental Genetic Disorders
Baker, E. K., Frazier, T. W., Phillips, J. M., Hardan, A. Y., & Uljarević, M. (2025) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-025-07069-3 · Cited by 2
“…autism, gross and fine motor delays, and other neurobehavioral profiles (Adegbola et al., 2015 ; Berg et al., 2024 ; Helsmoortel et al., 2014 ; Jafari Khamirani et al., 2022 ; Klaassens et al., 2015 ; Mo et al., 2022 ; Pilarski, 2019; Sabo et al., 2023 ; Vlaskamp et al., 2019; Xian et al., 2022 ).”
Brimble, E., Kim, J., Martin, R. L., McKnight, D., & Lacoste, A. M. B. (2023) · medRxiv · doi:10.1101/2023.03.02.23286645 · Cited by 2
Characterizing SCN1A -Related Disorders Using Real-World Data Across 681 Patient-YearsPreprint
Prentice, A. J., McSalley, I., Magielski, J. H., Mercurio, J., Tefft, S., Winters, A., Kaufman, M. C., Ruggiero, S. M., McGarry, L. M., Hood, V. L., et al. (2026) · medRxiv · doi:10.64898/2026.02.24.26346493 · Cited by 2
Self-citationBase editing the synapse: Modeling a complex neurological disorder in non-human primates
Prosser, B. L., & Helbig, I. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.05.009 · Cited by 1
Self-citationLi, X., Geng, X., Fan, J., Yan, F., Wang, R., Yang, Z., Li, Y., Wang, J., Luo, Y., & Zhao, H. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04699-7 · Cited by 1
Sharma, A., Anand, S., Kooper, C. C., van Putten, M. J. A. M., Avrămiea, A.-E., Diachenko, M., Bouman, A., Mercken, W., Ramautar, J. R., Mansvelder, H. D., et al. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1725623 · Cited by 1
Self-citationDominicis, A. D., Mercier, M., Pavia, G. C., Piscitello, L. M., Cappelletti, S., Filosomi, C., Correale, C., Calabrese, C., Palma, L. D., Novelli, A., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000214761 · Cited by 1
Quantification of Neuromotor Control in STXBP1 -Related Disorders With Wearable Sensors
Orlando, J. M., Bane, B., Chisari, T., Magielski, J. H., Pierce, S. R., Cunningham, K. G., Woo, C., Tefft, S., Nolan, J., Ruggiero, S. M., et al. (2026) · Neurology Genetics · doi:10.1212/nxg.0000000000200439 · Cited by 1
Self-citationRezi, C. K., Doğanlı, C., Aslanyan, M. G., Chamlali, M., Mary, B., Callesen, N. L., Abu-Khesha, R. R. K., Diwan, G. D., Russell, R. B., Lorentzen, E., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1805468 · Cited by 1
“The importance of STXBP1 in neuronal function is emphasized by the high prevalence of neuronal disorders associated with pathogenic variants in the corresponding gene (Xian et al., 2022).”
DYT-THAP1: exploring gene expression in fibroblasts for potential biomarker discovery
Diaw, S. H., Delcambre, S., Much, C., Ott, F., Kostić, V., Gajos, A., Münchau, A. M., Zittel, S., Busch, H. S., Grünewald, A., et al. (2024) · Neurogenetics · doi:10.1007/s10048-024-00752-0 · Cited by 1
“A different pattern of gene expression among the three groups was observed for two genes, STXBP1 and TOR1A , in which pathogenic variants cause neurological disorders like dystonia, tremor, ataxia, and spasticity [ 18 , 19].”
Self-citationOptimizing clinical interpretability of functional evidence in epilepsy-related ion channel variantsPreprint
Parthasarathy, S., Cohen, S. R., Fitch, E., Vaidiswaran, P., Ruggiero, S. M., Lusk, L. G., Chisari, V., Lewis‐Smith, D., Lauxmann, S., Boßelmann, C. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.09.593343 · Cited by 1
Self-citationSynaptic Vesicle Cycling Disorders: Cross-Sectional Phenotyping Study of a Gene Functional NetworkPreprint
Eck, J., Smith, T. A., Kolesnik, A., Al‐Jawahiri, R., & Baker, K. (2024) · medRxiv · doi:10.1101/2024.10.17.24315676 · Cited by 1
Self-citationKádková, A., Murach, J., Østergaard, M., Malsam, A., Malsam, J., Lolicato, F., Nickel, W., Söllner, T. H., & Sørensen, J. B. (2024) · doi:10.7554/elife.88619.2
Apport de la génétique dans la prise en charge des épilepsies de l’enfant
Bar, C., & Milh, M. (2022) · Perfectionnement en Pédiatrie · doi:10.1016/j.perped.2022.04.009
Kádková, A., Murach, J., Pedersen, M. Ø., Malsam, A., Malsam, J., Söllner, T. H., & Sørensen, J. B. (2023) · eLife · doi:10.7554/elife.88619.1
Could Neonatal Electroclinical Syndromes Orchestrate Diagnosis and Treatment?
Machado, R. A. (2024) · Journal of Experimental Neurology · doi:10.33696/neurol.5.083
Cilio, M. R., Carapancea, E., & Sands, T. T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00084-6
Vergara, M. A. M., Urrego, J. F. G., & Giraldo, L. J. M. (2025) · Journal of Biochemical and Clinical Genetics · doi:10.24911/jbcgenetics.11-2231
Kessi, M., Chen, B., Shan, L., Wang, Y., Yang, L., Yin, F., He, F., Peng, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26573392
Kessi, M., Chen, B., Shan, L., Wang, Y., Yang, L., Yin, F., He, F., Peng, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26573398
Metadata
- Authors
- Xian, J., Parthasarathy, S., Ruggiero, S. M., Balagura, G., Fitch, E., Helbig, K., Gan, J., Ganesan, S., Kaufman, M. C., Ellis, C. A., Lewis-Smith, D., Galer, P., Cunningham, K., O’Brien, M., Cosico, M., Baker, K., Darling, A., Veiga de Goes, F., El Achkar, C. M., Doering, J. H., Furia, F., García-Cazorla, Á., Gardella, E., Geertjens, L., Klein, C., Kolesnik-Taylor, A., Lammertse, H., Lee, J., Mackie, A., Misra-Isrie, M., Olson, H., Sexton, E., Sheidley, B., Smith, L., Sotero, L., Stamberger, H., Syrbe, S., Thalwitzer, K. M., van Berkel, A., van Haelst, M., Yuskaitis, C., Weckhuysen, S., Prosser, B., Son Rigby, C., Demarest, S., Pierce, S., Zhang, Y., Møller, R. S., Bruining, H., Poduri, A., Zara, F., Verhage, M., Striano, P., & Helbig, I.
- Affiliations
- Children's Hospital of Philadelphia (US)
- Istituto Giannina Gaslini (IT)
- Sichuan University (CN)
- Translational and Clinical Research Institute, Newcastle University , Newcastle-upon-Tyne NE2 4HH, UK
- MRC Cognition and Brain Sciences Unit (GB)
- Hospital Sant Joan de Déu Barcelona (ES)
- Department of Pediatrics and Pediatric Neurology Laboratory, Instituto Fernandes Figueira , Rio de Janeiro 22250-020, Brazil
- Division of Epilepsy and Clinical Neurophysiology and Epilepsy Genetics Program, Department of Neurology, Boston Children's Hospital , Boston, MA, USA
- University Hospital Heidelberg (DE)
- Filadelfia (DK)
- Pediatric Neurology Department, Hospital Sant Joan de Déu, University of Barcelona , Barcelona, Spain
- Amsterdam University Medical Centers (NL)
- Children's Hospital Colorado (US)
- MRC Cognition and Brain Sciences Unit, University of Cambridge , Cambridge, UK
- Samsung Medical Center (KR)
- Department of Human Genetics, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam University Medical Center , de Boelelaan 1085, 1081 HV Amsterdam, The Netherlands
- Boston Children's Hospital (US)
- Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (BR)
- Antwerp University Hospital (BE)
- Department of Functional Genomics, Center for Neurogenomics and Cognitive Research (CNCR), VU University Amsterdam , De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands
- University of Antwerp (BE)
- Department of Physiology, University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104, USA
- STXBP1 Foundation , Apex, NC 27539, USA
- Peking University (CN)
- Corresponding author
- Helbig, Ingo
- ORCID
- Xian, Julie
- Parthasarathy, Shridhar
- Ruggiero, Sarah M
- Balagura, Ganna
- Helbig, Katherine
- Gan, Jing
- Ganesan, Shiva
- Kaufman, Michael C
- Ellis, Colin A
- Lewis-Smith, David
- Galer, Peter
- Cunningham, Kristin
- Cosico, Mahgenn
- Baker, Kate
- Darling, Alejandra
- Furia, Francesca
- Gardella, Elena
- Geertjens, Lisa
- Lammertse, Hanna
- Lee, Jeehun
- Olson, Heather
- Sexton, Emma
- Sheidley, Beth
- Smith, Lacey
- Stamberger, Hannah
- Syrbe, Steffen
- Thalwitzer, Kim Marie
- Yuskaitis, Christopher
- Weckhuysen, Sarah
- Demarest, Scott
- Pierce, Samuel
- Zhang, Yuehua
- Møller, Rikke S
- Bruining, Hilgo
- Poduri, Annapurna
- Zara, Federico
- Verhage, Matthijs
- Striano, Pasquale
- Helbig, Ingo
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-11-23
- Volume
- 145
- Issue
- 5
- Pages
- 1668-1683
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC9166568
- OpenAlex
- W4206071515
- Cited by
- 130
- References
- 40
- Citations by year
- 2026: 28 · 2025: 30 · 2024: 39 · 2023: 18 · 2022: 15
- FWCI
- 12.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- VU Research Portal (publishedVersion, other-oa)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Arca - Repositório Institucional da Fiocruz (submittedVersion, other-oa)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Children's Hospital of Philadelphia (UL1TR001878, HD086984, U54 HD086984)
- Hartwell Foundation
- University of Pennsylvania (UL1 TR001878, U54HD086984)
- Institute for Translational Medicine and Therapeutics (UL1TR001878)
- Wellcome Trust (203914/Z/16/Z)
- European Science Foundation (HE5415/3‐1, HE5415/5-1, HE5415/6-1)
- Great Ormond Street Hospital Charity
- Deutsche Forschungsgemeinschaft (We4896/4-570 1, FOR‐2715, 2018-2022, HE 5415/6-1, HE5415/5‐1, HE5415/7-1, WE4896/3-1, HE5415/3-1, We4896/4-570, INTER/DFG/17/11583046)
- Fonds Wetenschappelijk Onderzoek
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (024.004.012, NWO 024.004.012)
- Ministero dell’Istruzione, dell’Università e della Ricerca (20182022, legge 232 del 2016, MIUR 2018-2022)
- National Institutes of Health (2018-2022, HD086984, UL1TR001878)
- Intellectual and Developmental Disabilities Research Center (U54 HD086984)
- Perelman School of Medicine, University of Pennsylvania (MDBR-20-136-STXBP1, UL1TR001878)
- Medical Research Council (MC_UU_00030/3, G101400)
- National Institute of Neurological Disorders and Stroke (K23NS107646, K02NS112600, T32NS091008, U24NS120854, K23NS121520)
- National Institute of Child Health and Human Development
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD086984, P50HD105351)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- STXBP1, neurodevelopmental disorders, phenotypic spectrum, seizures, infantile spasms, West syndrome, focal seizures, truncating mutations, recurrent variants, seizure history, seizure control, antiepileptic drugs, ketogenic diet, phenobarbital, ACTH, seizure onset
- MeSH terms
- Electroencephalography, Epilepsy, Humans, Infant, Retrospective Studies, Seizures, Spasms, Infantile, Munc18 Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.